FDA Warning Letters: Nov. 4
This article was originally published in The Gray Sheet
Executive Summary
The agency posted four device-focused warning letters Nov. 4, including one detailing quality systems violations by diagnostics firm BioMerieux, which had disclosed the letter after receiving it last month.